Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pluristem
Biotech
NASA-partnered Pluristem crashes to Earth
Israeli biotech Pluristem is canning its experimental phase 3 critical limb ischemia therapy after an outside review said it was no good.
Ben Adams
Dec 10, 2020 7:25am
BARDA rejects Pluristem's request for radiation study funding
Mar 3, 2020 8:40am
Pluristem’s cell therapies head for orbit with NASA deal
Feb 20, 2019 9:46am
Thermo Fisher, Pluristem link up to industrialize cell therapies
Jul 9, 2018 5:08pm
Pluristem sets June target for phase 2 cell therapy readout
May 10, 2018 11:47am
EuroBiotech: More Articles of Note
Jun 22, 2017 10:10am
